Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model.
about
The roles of retinoic acid and retinoic acid receptors in inducing epigenetic changesHistone deacetylase inhibitors and epigenetic modifications as a novel strategy in renal cell carcinomaPhase I trial of ATRA-IV and Depakote in patients with advanced solid tumor malignancies.Retinoic acid receptors and GATA transcription factors activate the transcription of the human lecithin:retinol acyltransferase gene.Novel and emerging targeted-based cancer therapy agents and methods.Phase I study of the histone deacetylase inhibitor entinostat in combination with 13-cis retinoic acid in patients with solid tumours.Molecular concepts analysis links tumors, pathways, mechanisms, and drugsA functional genetic screen identifies retinoic acid signaling as a target of histone deacetylase inhibitorsCombination therapy: histone deacetylase inhibitors and platinum-based chemotherapeutics for cancerHDAC inhibitors in kidney development and disease.Recent advances of cocktail chemotherapy by combination drug delivery systems.Targeting of histone deacetylases to reactivate tumour suppressor genes and its therapeutic potential in a human cervical cancer xenograft model.Histone modifications: implications in renal cell carcinoma.Blocking the PAH2 domain of Sin3A inhibits tumorigenesis and confers retinoid sensitivity in triple negative breast cancerGene regulation in the vascular endothelium: why epigenetics is important for the kidney.The epigenetics of renal cell tumors: from biology to biomarkers.The role of HIF1α in renal cell carcinoma tumorigenesis.New insights on chromatin modifiers and histone post-translational modifications in renal cell tumours.Molecular determinants of retinoic acid sensitivity in pancreatic cancer.Vorinostat combined with bexarotene for treatment of cutaneous T-cell lymphoma: in vitro and phase I clinical evidence supporting augmentation of retinoic acid receptor/retinoid X receptor activation by histone deacetylase inhibition.Gene microarray analysis of human renal cell carcinoma: the effects of HDAC inhibition and retinoid treatment.Epigenome Aberrations: Emerging Driving Factors of the Clear Cell Renal Cell Carcinoma.Therapeutic effects of histone deacetylase inhibitors on kidney disease.The epigenetic landscape of clear-cell renal cell carcinoma.Overview of the Classical Histone Deacetylase Enzymes and Histone Deacetylase Inhibitors
P2860
Q26866044-15300138-E4DD-40A0-8BE6-E03EBC63690EQ27025984-65F8B4B7-91ED-4370-8FE0-0F25C5968E82Q33388447-F473B929-DF53-4154-928B-C37156EC9559Q34656797-73FB12D0-910A-4996-9185-63D56C7EAE63Q35558057-B9A9D0F9-64CD-4A5D-8CD3-A75E92C121BFQ35653852-D5592ADC-C2C3-47FA-A8AF-EF41F688C498Q35812701-8428FDBD-74DA-431B-A7CD-B3D65E12F117Q36140582-31705C18-3FD5-4A44-A478-E3C549EC003FQ36537920-D21749E0-9828-4C3B-B5CF-DED7FDDC6A92Q37115414-15D6863F-443B-493D-8B83-251717A53D68Q37206908-AADF2F7F-98BD-4EE8-AB61-AB7AA399DC3BQ37325233-654F3570-ECCB-4A34-B101-A382A352B693Q37414110-AA0B139C-46D9-4C4D-A41A-CA736F8861A6Q37536680-0EC410F0-DBFF-4BD0-931C-98D575E3DC30Q37637391-BF7B8255-70D5-4A39-B9D3-2F8A450951B9Q38016153-551C30BE-F94D-4B75-A60A-2CA8CA2D51DDQ38219283-95FF0735-AE9F-4CC7-AD8D-76A77597DA13Q38294198-6756E587-1B35-40CB-AC06-070ABF4E92AAQ38331001-687E1150-C4A7-4FD9-8C45-CB19EC48BC57Q39253408-6D994DF7-4BE0-4401-9DAA-341C49458BE3Q39943631-CD171867-DE8B-46D0-A4AB-E873E5F1BF07Q41574276-FA002817-BDCB-496D-9BAC-9095A8E7EB14Q48136812-E17878E6-2650-43FE-96D5-D2C9A0ADE4A7Q51091490-5E64B735-B6AC-4B92-831E-12146873EA82Q58689803-E2D01AA2-B9CF-49BB-82EF-6F920D897DC0
P2860
Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Retinoic acid and the histone ...... ma in a xenograft tumor model.
@en
type
label
Retinoic acid and the histone ...... ma in a xenograft tumor model.
@en
prefLabel
Retinoic acid and the histone ...... ma in a xenograft tumor model.
@en
P2093
P1476
Retinoic acid and the histone ...... ma in a xenograft tumor model.
@en
P2093
David M Nanus
Jonathan S Goldberg
Lorraine J Gudas
Paul Moench
Satish K Tickoo
Sue Ellen Touma
Xiaojia Guo
P304
P356
10.1158/1078-0432.CCR-04-1155
P407
P577
2005-05-01T00:00:00Z